BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9199975)

  • 1. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
    George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
    Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
    Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
    J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
    Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
    J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cardiolipin antibody from a patient with antiphospholipid syndrome (APS) recognizes only an epitope expressed by cardiolipin/beta 2-glycoprotein-I (beta 2GPI) complex and induces APS.
    Levy Y; Sherer Y; Mathieu A; Cauli A; Passiu G; Sanna G; Janackovic Z; Blank M; Shoenfeld Y
    Clin Exp Rheumatol; 2000; 18(4):479-84. PubMed ID: 10949723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
    Wagenknecht DR; McIntyre JA
    Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.
    Teixidó M; Font J; Reverter JC; Cervera R; Tàssies D; Ingelmo M; Escolar G; Ordinas A
    Br J Rheumatol; 1997 Jan; 36(1):113-6. PubMed ID: 9117149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
    Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
    J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
    Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
    Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies differ in aPL cofactor requirement.
    Sammaritano LR; Lockshin MD; Gharavi AE
    Lupus; 1992 Feb; 1(2):83-90. PubMed ID: 1301968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipid.
    Keeling DM; Wilson AJ; Mackie IJ; Machin SJ; Isenberg DA
    Br J Haematol; 1992 Nov; 82(3):571-4. PubMed ID: 1486037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.
    Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL
    Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I.
    Roubey RA; Pratt CW; Buyon JP; Winfield JB
    J Clin Invest; 1992 Sep; 90(3):1100-4. PubMed ID: 1522218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of immunoassays for antiphospholipid antibodies with beta 2GPI and role of other phospholipid cofactors.
    Amiral J; Larrivaz I; Cluzeau D; Adam M
    Haemostasis; 1994; 24(3):191-203. PubMed ID: 7527366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
    Arvieux J; Roussel B; Colomb MG
    Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
    Valesini G; Shoenfeld Y
    Autoimmunity; 1992; 14(2):105-10. PubMed ID: 1303677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
    Balestrieri G; Tincani A; Spatola L; Allegri F; Prati E; Cattaneo R; Valesini G; Del Papa N; Meroni P
    Lupus; 1995 Apr; 4(2):122-30. PubMed ID: 7795615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
    Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.